Drug Store News - Warner Chilcott files ANDA for terazosin hydrochloride capsules
Wednesday, December 31st, 2008Warner Chilcott PLC has filed an abbreviated new drug application with the FDA for an AB rateable form of terazosin hydrochloride capsules, said to be a bioequivalent of Abbott Laboratories’ Hytrin alpha blocker.
Related Results
Common prostate drug is ineffective - Hytrin works better - Hytrin vs ProscarMylan receives approval for generic HytrinTorP…
